The Clinical Research Unit at the Montreal Neurological Institute and Hospital began as part of the Multiple Sclerosis Clinic under the direction of Dr. Gordon Francis in 1986. At that time it was involved with the first MS clinical trials that would lead to the approved injectable treatments that are in use today. These therapies, however, are not a cure for MS. The CRU continues to be involved in the search for better and more effective therapies for multiple sclerosis medications that are more effective and easier to administer. Several recent studies have involved intravenous infusions of medication or oral medications.

In January 2005, the current director, Dr. Angela Genge was appointed the director of the CRU. The CRU continues to branch out into new clinical neuroscience domains and is now involved in clinical drug and/or device trials for the following neurological conditions: MS, ALS, epilepsy, stroke, cerebral hemorrhage, Parkinson’s, and other movement disorders, muscle diseases, diseases of the spine, myasthena gravis, muscular dystrophies and other neuromuscular diseases, brain tumours, neuropathic pain, migraines and intracerebral aneurysm.

CRU TODAY (2012)

The CRU is located on the 2nd floor, suite 207. The physiotherapy department, the neurology day center and the multidisciplinary clinics are also located on the 2nd floor.

The CRU employs dedicated staff members which include a director, manager, financial officer, study coordinators, nursing and ethics support. We are currently involved in 50 clinical trials and have patients referred to us from Ontario, Quebec and the Atlantic provinces.

The CRU works closely with the Experimental Therapeutics Program, led by Dr. Amit Bar-Or, which pursues translational research in neurology and autoimmune diseases.

We also work with the Brain Imaging Centre which has a vast expertise in MRI and MRS research.